Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD-Reference-Cited by-同舟云学术

Two-Step Strategy, FIB-4 Followed by Magnetic Resonance Elastography, for Detecting Advanced Fibrosis in NAFLD

Published:2023-02 Issue:2 Volume:21 Page:380-387.e3
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Tamaki Nobuharu,Imajo Kento,Sharpton Suzanne R.,Jung Jinho,Sutter Nancy,Kawamura Nobuyoshi,Yoneda Masato,Valasek Mark A.,Behling Cynthia,Sirlin Claude B.,Kurosaki Masayuki,Izumi Namiki,Nakajima Atsushi,Loomba Rohit^ORCID

Funder

NHLBI

NIAAA

NIDDK

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference31 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroenterol Hepatol,2018

2. The global NAFLD epidemic;Loomba;Nat Rev Gastroenterol Hepatol,2013

3. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention;Huang;Nat Rev Gastroenterol Hepatol,2021

4. Hepatocellular carcinoma and other complications of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: a structured review of published works;Eguchi;Hepatol Res,2021

5. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis;Dulai;Hepatology,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population screening for cirrhosis;Hepatology Communications;2024-08-26

2. Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic-Dysfunction-Associated Steatohepatitis;Seminars in Liver Disease;2024-07-09

3. Enhanced Liver Fibrosis Score for Diagnosing Liver Fibrosis in Chronic Hepatitis;Diagnostics;2024-06-21

4. US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening;Radiology;2024-04-01

5. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease;Protein & Peptide Letters;2024-04